| Author/Year |
Clinical condition |
Outcome measures used for meta‐analyses |
| Adibe 2013a |
Diabetes (Type 2) |
‐ |
| Adler 2004 |
Major depression and/or dysthymia |
‐ |
| Albsoul‐Younes 2011 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Ali 2012 |
Diabetes (Type 2) |
Fasting blood glucose (mmol/l) |
| Amariles 2012 |
Cardiovascular disease |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); Total cholesterol (mmol/L) |
| Andres 2007 |
Diabetes (Type 2) |
HbA1c (%) |
| Armour 2007 |
Asthma |
‐ |
|
Barbanel 2003‐
|
Asthma |
‐ |
| Bernsten 2001 |
Older Patients (aged > 65) |
Hospital attendance/admission |
| Blalock 2010 |
At‐risk patients (Older patients (aged > 65) receiving medication that increases their risk of falling) |
‐ |
| Bogden 1998 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Bond 2000 |
Repeat prescribing |
Hospital attendance/admission; Adverse drug effects |
| Borenstein 2003a |
Hypertension |
% outside blood pressure range |
| Bosnic‐Anticevich 2010 |
Asthma/Chronic Obstructive Pulmonary Disease (COPD) |
‐ |
| Boyd 2013 |
Non‐adherence in chronic conditions |
‐ |
| Brook 2003 |
Depression |
‐ |
| Bruhn 2013 |
Pain (Chronic) |
‐ |
| Capoccia 2004 |
Depression |
‐ |
| Castejon 2013 |
Diabetes |
% outside HbA1c range; HbA1c (%) |
| Carter 2008 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Charrois 2006 |
Asthma |
Hospital attendance/admission |
| Chisholm 2002 |
Transplant patients (renal with focus on BP control) |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Choe 2005 |
Diabetes (Type 2) |
HbA1c (%) |
| Chrischilles 2014 |
Adults with disability |
Adverse drug effects |
| Clifford 2005 |
Diabetes (Type 2) (vascular risk factors) |
HbA1c (%) |
| Cody 1998 |
Health Related Quality of Life (Short Form Survey 36) |
‐ |
| Cordina 2001 |
Asthma |
‐ |
| De Castro 2006 |
Hypertension |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Di Donato 2014 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Doucette 2009 |
Diabetes |
HbA1c (%); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); LDL Cholesterol (mmol/L) |
| Edwards 2014 |
Chemotherapy |
‐ |
| Farsaei 2011 |
Diabetes (Type 2) |
% outside HbA1c range; HbA1c (%); Fasting blood glucose (mmol/l) |
| Faulkner 2000 |
Hypercholesterolaemic patients receiving combination drug therapy |
Total cholesterol (mmol/L); LDL Cholesterol (mmol/L) |
| Finley 2003 |
Depression |
‐ |
| Garção 2002 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| García‐Cárdenas 2013 |
Asthma |
‐ |
| Gattis 1999a |
Heart failure |
Mortality |
| González‐Martin 2003 |
Asthma |
Forced expiratory volume (FEV1) |
| Goodyer 1995 |
Heart failure |
‐ |
| Green 2008 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Hammad 2011 |
Metabolic syndrome |
Fasting blood glucose (mmol/l); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Hawes 2013 |
Patients at risk of rehospitalisation |
Hospital attendance/admission |
| Hawkins 1979 |
Hypertension and Diabetes |
Diastolic blood pressure (mmHg) (Comparison 2) |
| Hay 2006 |
Knee pain |
‐ |
| Hendrie 2014 |
Type 2 Diabetes |
‐ |
| Hirsch 2014 |
Blood pressure |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Ho 2013 |
Acute Coronary Syndrome |
% outside blood pressure range;Hospital attendance/admission; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); LDL Cholesterol (mmol/L); Mortality |
| Holland 2005 |
Multiple conditions |
‐ |
| Hunt 2008 |
Hypertension |
% outside blood pressure range; SF‐36 physical functioning; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Jaber 1996 |
Diabetes |
Fasting blood glucose (mmol/l) |
| Jackson 2004 |
Anticoagulation (Warfarin) |
Hospital attendance/admission; Mortality |
| Jahangard‐Rafsanjani 2014 |
Diabetes |
HbA1c (%); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Jarab 2012 |
Chronic Obstructive Pulmonary Disease |
Hospital attendance/admission; Forced expiratory volume (FEV1) |
| Khdour 2009 |
Chronic Obstructive Pulmonary Disease |
Forced expiratory volume (FEV1) |
| Krass 2007 |
Diabetes |
HbA1c (%); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Kritikos 2007 |
Asthma |
‐ |
| Krska 2001 |
Multiple conditions |
‐ |
| Lai 2013 |
Osteoporosis (postmenopausal) |
‐ |
| Lee 2006 |
Elderly with coronary risk factors |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Lenaghan 2007 |
Multiple conditions |
Mortality |
| Lenander 2014 |
Polypharmacy (> 5 medications) |
‐ |
| Li 2014 |
Chronic Obstructive Pulmonary Disease |
‐ |
| Lopez 2006 |
Heart failure |
Hospital attendance/admission; Mortality |
| Losada‐Camacho 2014 |
Epilepsy |
‐ |
| Magid 2013 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Mahwi 2013 |
Diabetes (Type 2) |
HbA1c (%); Fasting blood glucose (mmol/l) |
| Malone 2001 |
At‐risk patients (high risk of drug related problems (DRPs)) |
Total cholesterol (mmol/L) |
| Margolis 2013 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); |
| Marques 2013 |
Depression |
‐ |
| Marra 2012 |
Osteoarthritis (Knee) |
‐ |
| Mazroui 2009 |
Type 2 diabetes |
SF‐36 physical functioning; HbA1c (%); Fasting blood glucose (mmol/l); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg);Total cholesterol (mmol/L) |
| McAlister 2014 |
Cerebrovascular Accident (BP/lipid levels after stroke) |
Systolic blood pressure (mmHg) (Comparison 2) |
| Mehos 2000 |
Hypertension |
SF‐36 physical functioning; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Mehuys 2008 |
Asthma |
Hospital attendance/admission; Peak Flow (%) |
| Milos 2013 |
Multiple conditions |
‐ |
| Murray 2007 |
Heart failure |
‐ |
| Naunton 2003 |
Multiple conditions |
Hospital attendance/admission; Mortality |
| Obreli‐Neto 2015 |
Older patients (with diabetes and hypertension) |
% outside blood pressure range;% outside HbA1c range; HbA1c (%); Fasting blood glucose (mmol/l); Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); LDL Cholesterol (mmol/L) |
| Okamoto 2001 |
Hypertension |
Systolic blood pressure (mmHg) (Comparison 2); Diastolic blood pressure (mmHg) (Comparison 2) |
| Olesen 2014 |
Polypharmacy (older patients) |
Hospital attendance/admission; Mortality |
| Park 1996 |
Hypertension |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Paulos 2005 |
Dyslipidaemia |
Total cholesterol (mmol/L) |
| Peterson 2004 |
Dyslipidaemia |
Total cholesterol (mmol/L) |
| Reid 2005 |
Hypertension |
% outside blood pressure range |
| Rickles 2005 |
Depression |
‐ |
| Rothman 2005 |
Diabetes (Type 2) |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Rubio‐Valera 2012 |
Depression |
‐ |
| Sadik 2005 |
Heart failure |
SF‐36 physical functioning |
| Salazar‐Ospina 2017 |
Bipolar Diseases |
‐ |
| Samtia 2013 |
Diabetes (Type 2) |
HbA1c (%); Fasting blood glucose (mmol/l) |
| Sarkadi 2004 |
Diabetes (Type 2) |
HbA1c (%) |
| Schneider 1982 |
Hypertension and Congestive Heart Failure |
‐ |
| Schneiderhan 2014 |
Metabolic Syndrome |
% outside HbA1c range |
| Sellors 2003 |
Multiple conditions |
SF‐36 physical functioning |
| Sidel 1990 |
Multiple conditions |
‐ |
| Silveira 2014 |
HIV |
‐ |
| Simpson 2011 |
Diabetes (Type 2) |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg);Total cholesterol (mmol/L); LDL Cholesterol (mmol/L) |
| Solomon 1998 |
Chronic Obstructive Pulmonary Disease |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg); Dyspnoea |
| Sookaneknun 2004 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Stewart 2014 |
Hypertension (primary) |
Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Suppapitiporn 2005 |
Type 2 diabetes |
HbA1c (%) |
| Tang 2014 |
Epilepsy |
‐ |
| Tannenbaum 2014 |
Benzodiazepine users |
‐ |
| Taveira 2011 |
Cardiovascular risk |
% outside HbA1c range; HbA1c (%); Systolic blood pressure (mmHg); LDL Cholesterol (mmol/L) |
| Taveira 2014 |
Cardiovascular risk |
‐ |
| Taylor 2003 |
Multiple conditions |
SF‐36 physical functioning |
| Tommelein 2013 |
Chronic Obstructive Pulmonary Disease |
Dyspnoea |
| Tsuyuki 2002 |
Cardiacovascular risk; atherosclerotic disease or diabetes |
‐ |
| Tsuyuki 2015 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Verret 2012 |
Anticoagulant patients/stroke risk |
Hospital attendance/admission; Adverse drug effects; Mortality |
| Vivian 2002 |
Hypertension |
% outside blood pressure range; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Volume 2001 |
Polypharmacy (older patients > 3 medications) |
‐ |
| Wal 2013 |
Hypertension |
SF‐36 physical functioning; Diastolic blood pressure (mmHg); Systolic blood pressure (mmHg) |
| Weinberger 2002 |
Chronic Obstructive Pulmonary Disease |
Hospital attendance/admission; Peak Flow (%) |
| Wu 2006 |
Various |
Mortality |
| Zermansky 2001 |
Multiple conditions |
Hospital attendance/admission |
